Active Biotech AB publ

Active Biotech AB publ FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Active Biotech AB publ (ACTI.ST) as of Nov 3, 2026 is 173.73 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 102.54 % — a change of 69.43% (higher).

FCF Conversion

173.73 %

YoY

69.43%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Active Biotech AB publ is 2025 173.73 % . FCF Conversion Rate (FCF/EBITDA) of Active Biotech AB publ was 2024 102.54 % . It decreases by 69.43% higher compared to the previous year.

The Active Biotech AB publ FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
110.22 SEK
Jan 1, 2019
99.30 SEK
Jan 1, 2020
100.31 SEK
Jan 1, 2021
92.55 SEK
Jan 1, 2022
93.87 SEK
Jan 1, 2023
99.87 SEK
Jan 1, 2024
102.54 SEK
Jan 1, 2025
173.73 SEK
The Active Biotech AB publ FCF Conversion history
YEARFCF ConversionYoY
173.73 %+69.43%
102.54 %+2.67%
99.87 %+6.39%
93.87 %+1.43%
92.55 %-7.74%
100.31 %+1.02%
99.30 %-9.91%
110.22 %+158.17%
42.69 %-65.23%
122.79 %+9.06%
112.59 %-3.10%
116.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Active Biotech AB publ Stock analysis

What does Active Biotech AB publ do? Active Biotech AB (publ) is a Swedish biopharmaceutical company specializing in the research and development of drugs for the treatment of autoimmune diseases and cancer. The company was founded in 1990 and is headquartered in Lund, Sweden. Active Biotech AB publ is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Active Biotech AB publ stock

FCF Conversion Rate (FCF/EBITDA) of Active Biotech AB publ is 173.73 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Active Biotech AB publ changed from 102.54 % to 173.73 %, representing a 69.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Active Biotech AB publ since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Active Biotech AB publ with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Active Biotech AB publ

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Active Biotech AB publ